Compound ID | 1309
Salvecin
Synonym(s): Tosatoxumab | AR-301 | AR301 | AR 301 | KBSA-301 | KBSA 301 | KBSA301
Class: Antibody
| Agent Type: | Natural product; Indirect acting; Antivirulence; Antibody; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Targets secreted alpha-hemolysin / alpha-toxin |
| Target Pathogen: | Active against Staphylococcus aureus |
| Description: | Adjunctive therapy for VAP caused by Staphylococcus aureus |
| Institute where first reported: | Aridis |
| Highest development stage: | Phase 3 (NCT03816956) |
| Development status: | Active |
| External links: | |
| Guide to Pharmacology: | tosatoxumab |
| Citations: |
|
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.